Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 USD | -0.56% | -3.87% | +3.77% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.77% | 285B | |
+29.68% | 681B | |
+20.37% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+13.60% | 235B | |
+4.49% | 199B | |
-12.43% | 189B | |
-3.79% | 157B | |
-3.34% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Barclays Adjusts Price Target on AbbVie to $185 From $175, Maintains Overweight Rating